CLSH

CLS Holdings USA earns a Neutral rating, with a 42.1 composite score and conviction of two out of five. Regulatory is the strongest pillar at 49, supported by an 80 enforcement subscore, a 50 jurisdiction assessment, and no recorded enforcement hits. Fundamentals contributes 44, balancing strong gross-margin and operating-margin subscores against contracting sales, negative EBITDA, and a negligible market-cap tier contribution. Market contributes 40 despite the absence of an available quote from institutional pricing feeds, limiting evidence of price discovery and trading support. Editorial contributes 30, reflecting no newsroom or brief activity in CIN newsroom coverage. The resulting profile sits firmly in the Neutral band: operating economics retain measurable strengths, while weak growth, limited market visibility, and sparse disclosure cadence cap conviction.

Licensed fundamentals data shows year-over-year revenue contracting by 21.8%, the clearest drag on the fundamental assessment and consistent with the 28.2 revenue-growth subscore. Gross margin remains comparatively constructive at approximately 41.7%, underpinning the 69.5 gross-margin subscore. Operating margin stands near negative 10.2%, while EBITDA is negative by roughly $815,000; reported net income, however, remains positive at about $460,000. The cash-burn ratio is approximately 0.14, and the financial condition is classified as stable, supporting a 54.9 cash-runway subscore without offsetting the pressure from sales contraction. Primary regulatory filings show no identified events across either the latest 90-day or 180-day windows, no enforcement hits, and no available latest-filing date. That record supports enforcement standing but leaves filing cadence at only 25.

The clearest forward catalyst sits within the regulatory pillar because it already leads the scorecard and carries the strongest individual driver through the 80 enforcement subscore. A current primary regulatory filing would improve transparency, establish a verifiable reporting timeline, and strengthen the weakest component inside the leading pillar without relying on market-price momentum or editorial attention. More consistent filing activity would also provide fresher evidence on whether gross-margin resilience can persist while revenue contracts and EBITDA remains negative. The single most important signal to watch is the appearance of a current primary regulatory filing that restores a measurable disclosure cadence.